Heart, Lung and Circulation
Volume 18, Issue 2 , Pages 118-122, April 2009

Cost-effectiveness Considerations of Cardiovascular Therapeutics

  • Anthony Keech

      Affiliations

    • NHMRC Clinical Trials Centre and Department of Cardiology, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia
    • Corresponding Author InformationCorresponding author.
    • ,
  • John D. Horowitz

      Affiliations

    • Cardiology Unit, Queen Elizabeth Hospital, University of Adelaide, Adelaide, Australia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1443-9506(08)00953-0

doi:10.1016/j.hlc.2008.11.006

Heart, Lung and Circulation
Volume 18, Issue 2 , Pages 118-122, April 2009

Article Tools